sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals Europe Microbiome Therapeutics Market...

2030년까지 유럽 마이크로바이옴 치료제 시장 전망 - 유형별(치료제 및 절차), 용도별(대사 장애 및 비만, C. 난치성 감염, 염증성 장 질환 및 기타) 및 최종 사용자(병원 및 진료소, 외래 수술 센터)별 지역 분석 , 홈케어 등)

BMIRE00029955 | Pages: 71 | Pharmaceuticals | Apr 2024 | Type: Regional | Status: Published
유럽의 마이크로바이옴 치료제 시장은 2022년에 9,774만 달러로 평가되었으며, 2030년에는 2억 1,252만 달러에 이를 것으로 예상됩니다. 2022년부터 2030년까지 10.2%의 연평균 성장률(CAGR)을 기록할 것으로 추정됩니다. 미생물군집 발견 파이프라인을 개선하기 위한 자금 유입으로 유럽 미생물군집 치료제 시장 조사에 따르면 미생물군집의 불균형이나 혼란이 염증성 장 질환 및 비만은 물론 정신건강 장애까지. 전반적인 건강에서 미생물군집의 역할에 대한 인식은 미생물군집을 표적으로 삼고 조절하는 치료법 개발에 상당한 관심을 불러일으켰습니다. 또한 기술과 연구 도구의 발전으로 미생물군집을 연구하고 조작하는 것이 더 쉬워졌습니다. 차세대 염기서열 분석 및 메타게놈 분석을 통해 미생물 군집과 그 기능에 대한 더 깊은 이해가 가능해졌습니다. 지식의 증가로 표적 치료법 개발의 새로운 가능성이 열렸습니다. 예를 들어, 2023년 3월 독일의 마이크로바이옴 생명공학 회사인 mbiomics GmbH는 효과적인 1세대 마이크로바이옴 기반 치료제를 개발했습니다. MIG Capital로부터 1,300만 달러(미화 1,500만 달러)의 자금을 지원받았습니다. 이 자금을 통해 플랫폼을 구축하여 최초의 주요 약물 후보 식별을 가속화하고 임상 검증을 위한 연구 노력을 가속화할 수 있습니다. 강력한 임상 증거가 확보됨에 따라 투자자들은 마이크로바이옴 조절제 회사에 주목하기 시작했습니다. 강화된 자금은 기업이 높은 개발 및 생산 비용과 관련된 과제를 극복하고 궁극적으로 해당 분야를 발전시키는 데 필요한 자원을 제공합니다. 유럽 마이크로바이옴 치료제 시장 개요 독일의 마이크로바이옴 치료 연구 회사들은 마이크로바이옴 제품 개발을 위해 수행되는 연구의 질을 향상시키기 위해 다른 회사들에게 연구 활동에 투자하도록 요청하는 데 중점을 두고 있습니다. 2023년 3월, 마이크로바이옴에 중점을 둔 독일 생명공학 회사인 mbiomics GmbH는 MIG Capital이 주도하는 시리즈 A 자금 조달 라운드에서 ~US$ 1,500만(1,300만)을 받았습니다. mbiomics는 수익금을 전략적 파트너십에 착수하여 독일의 뮌헨 실험실 시설과 R&D 팀을 크게 확장하는 데 사용했습니다. 일부 FMT 절차에서는 감염원이 기증자에서 환자로 옮겨져 결과에 영향을 미칠 수 있습니다. 따라서 독일에서는 미생물군유전체 또는 FMT 절차 사용에 대한 특별한 규정을 설정했습니다. 독일에서는 FMT 약물이 의약품으로 규제됩니다. 그러나 이 제품의 사용은 C. difficile 감염 및 장 감염과 같은 상태에 다른 치료법이 효과가 없는 경우에만 수행할 수 있습니다. 따라서 마이크로바이옴 치료제 연구에 대한 투자 급증에도 불구하고 이러한 치료제 사용에 관한 규제는 독일의 유럽 마이크로바이옴 치료제 시장 성장을 방해할 수 있습니다. 유럽 마이크로바이옴 치료제 시장 수익 및 2030년 예측(미화 백만 달러) 유럽 마이크로바이옴 치료제 시장 세분화 유럽 마이크로바이옴 치료제 시장은 유형, 애플리케이션, 최종 사용자 및 국가를 기준으로 분류됩니다. 유형에 따라 유럽 마이크로바이옴 치료제 시장은 치료제와 시술법으로 구분됩니다. 시술 부문은 2022년에 더 큰 점유율을 차지했습니다. 치료 부문은 대변 미생물 이식(FMT), 프리바이오틱스 및 프로바이오틱스 등으로 더욱 세분화됩니다. 적용에 따라 유럽의 마이크로바이옴 치료제 시장은 대사 장애 및 비만, C. difficile 감염, 염증성 장 질환 등으로 분류됩니다. 대사 장애 및 비만 부문은 2022년에 가장 큰 점유율을 차지했습니다. 최종 사용자 기준으로 유럽 마이크로바이옴 치료제 시장은 병원 및 진료소, 외래 수술 센터, 홈케어 등입니다. 병원 및 진료소 부문은 2022년에 가장 큰 점유율을 차지했습니다. 국가를 기준으로 유럽 마이크로바이옴 치료제 시장은 영국, 독일, 프랑스, 이탈리아, 스페인 및 기타 유럽 지역으로 분류됩니다. 독일은 2022년 유럽 마이크로바이옴 치료제 시장을 장악했습니다. Caelus Health BV, Enterome SA, Ferring Holdings SA, Vedanta Biosciences Inc 및 YSOPIA Bioscience SA는 유럽 마이크로바이옴 치료제 시장에서 활동하는 선도적인 회사 중 일부입니다.
Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Microbiome Therapeutics Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

5. Europe Microbiome Therapeutics Market - Key Industry Dynamics

5.1 Europe Microbiome Therapeutics Market - Key Industry Dynamics

5.2 Key Market Drivers

5.2.1 Potential of Gut Microbiota in Maintaining Human Health

5.2.2 Inflow of Funds to Ameliorate Microbiome Discovery Pipeline

5.3 Key Market Restraints

5.3.1 High Cost of Development and Production

5.4 Key Market Opportunities

5.4.1 Increasing R&D to Gain Better Understanding of Human Microbiome

5.5 Key Future Trends

5.5.1 Technological Advancement in Human Microbiome Therapeutics

5.6 Impact of Drivers and Restraints:

6. Microbiome Therapeutics Market - Europe Market Analysis

7. Europe Microbiome Therapeutics Market Analysis - Type

7.1 Therapeutics

7.1.1 Overview

7.1.2 Therapeutics Market, Revenue and Forecast to 2030 (US$ Thousand)

7.2 Procedure

7.2.1 Overview

7.2.2 Procedure Market, Revenue and Forecast to 2030 (US$ Thousand)

8. Europe Microbiome Therapeutics Market Analysis - Application

8.1 Metabolic Disorder and Obesity

8.1.1 Overview

8.1.2 Metabolic Disorder and Obesity Market, Revenue and Forecast to 2030 (US$ Thousand)

8.2 C. Difficile Infection (CDI)

8.2.1 Overview

8.2.2 C. Difficile Infection (CDI) Market, Revenue and Forecast to 2030 (US$ Thousand)

8.3 Inflammatory Bowel Disease

8.3.1 Overview

8.3.2 Inflammatory Bowel Disease Market, Revenue and Forecast to 2030 (US$ Thousand)

8.4 Others

8.4.1 Overview

8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Thousand)

9. Europe Microbiome Therapeutics Market Analysis - End User

9.1 Hospitals and Clinics

9.1.1 Overview

9.1.2 Hospitals and Clinics Market, Revenue and Forecast to 2030 (US$ Thousand)

9.2 Ambulatory Surgical Centers

9.2.1 Overview

9.2.2 Ambulatory Surgical Centers Market, Revenue and Forecast to 2030 (US$ Thousand)

9.3 Homecare

9.3.1 Overview

9.3.2 Homecare Market, Revenue and Forecast to 2030 (US$ Thousand)

9.4 Others

9.4.1 Overview

9.4.2 Others Market, Revenue and Forecast to 2030 (US$ Thousand)

10. Europe Microbiome Therapeutics Market - Country Analysis

10.1. Europe Microbiome Therapeutics Market Revenue and Forecasts and Analysis - By Country

10.1.1 Europe Microbiome Therapeutics Market Revenue and Forecasts and Analysis - By Country

10.1.2 UK

10.1.2.1 UK: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.2.2 United Kingdom Europe Microbiome Therapeutics Market Breakdown by Type

10.1.2.2.1 UK: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.2.3 UK: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.2.4 UK: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.3 Germany

10.1.3.1 Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.3.2 Germany: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.3.2.1 Germany: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.3.3 Germany: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.3.4 Germany: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.4 France

10.1.4.1 France: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.4.2 France: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.4.2.1 France: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.4.3 France: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.4.4 France: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.5 Italy

10.1.5.1 Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.5.2 Italy: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.5.2.1 Italy: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.5.3 Italy: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.5.4 Italy: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.6 Spain

10.1.6.1 Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.6.2 Spain: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.6.2.1 Spain: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.6.3 Spain: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.6.4 Spain: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.7 Rest of Europe

10.1.7.1 Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.7.2 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.7.2.1 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.7.3 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.7.4 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by End User

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in Europe Microbiome Therapeutics Market

12. Company Profiles

12.1 YSOPIA Bioscience SA

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Ferring Holdings SA

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Enterome SA

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Caelus Health BV

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Vedanta Biosciences Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

List of Tables

Table 1. Europe Microbiome Therapeutics Market Segmentation

Table 2. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - Type

Table 3. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - Therapeutics

Table 4. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - Application

Table 5. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - End User

Table 6. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Country

Table 7. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 8. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 9. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 10. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 11. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 12. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 13. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 14. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 15. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 16. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 17. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 18. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 19. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 20. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 21. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 22. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 23. ADULT OBESITY, 2030

Table 24. CHILD OBESITY, 2030

Table 25. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 26. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 27. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 28. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 29. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 30. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 31. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 32. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 33. Recent Growth Strategies in Europe Microbiome Therapeutics Market

Table 34. Glossary of Terms, Europe Microbiome Therapeutics Market

List of Figures

Figure 1. Europe Microbiome Therapeutics Market Segmentation, By Country

Figure 2. Europe PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Europe Microbiome Therapeutics Market Revenue (US$ Thousand), 2022 - 2030

Figure 5. Europe Microbiome Therapeutics Market Share (%) - Type, 2022 and 2030

Figure 6. Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 7. Procedure Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 8. Europe Microbiome Therapeutics Market Share (%) - Application, 2022 and 2030

Figure 9. Metabolic Disorder and Obesity Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 10. C. Difficile Infection (CDI) Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 11. Inflammatory Bowel Disease Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 12. Others Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 13. Europe Microbiome Therapeutics Market Share (%) - End User, 2022 and 2030

Figure 14. Hospitals and Clinics Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 15. Ambulatory Surgical Centers Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 16. Homecare Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 17. Others Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 18. Europe Microbiome Therapeutics Market Breakdown by Key Countries - Revenue (2022) (US$ Thousand)

Figure 19. Europe Microbiome Therapeutics Market Breakdown by Key Countries, 2022 and 2030 (%)

Figure 20. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 21. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 22. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 23. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 24. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 25. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

1. Caelus Health BV

2. Enterome SA

3. Ferring Holdings SA

4. Vedanta Biosciences Inc

5. YSOPIA Bioscience SA

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe microbiome therapeutics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Europe microbiome therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the microbiome therapeutics market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
    • Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports
    Report Name Published Date
    Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022
    Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022
    Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022
    Purchase Options
    Single User License
    $3550
    $2840
    Site License
    $4550
    $3640
    Enterprise License
    $5550
    $4440
    GET FREE SAMPLE PDF
    Inquire before Buying Inquire for Discount
    Subscription Member Price: FREE
    Get Subscription